Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

How diagnostic tools impact therapy of haematological malignancies

Will circulating tumour DNA have a role in treatment decisions?

Date

09 Sep 2022

Session

How diagnostic tools impact therapy of haematological malignancies

Topics

Translational Research;  Cancer Diagnostics

Tumour Site

Lymphomas

Presenters

Florian Scherer

Authors

F. Scherer

Author affiliations

  • University Medical Center Freiburg, 79106 - Freiburg im Breisgau/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Acute myeloid leukaemia

Presenter: Lars Bullinger

Session: How diagnostic tools impact therapy of haematological malignancies

Resources:

Slides

Webcast

PET: New applications

Presenter: Marius Mayerhoefer

Session: How diagnostic tools impact therapy of haematological malignancies

Resources:

Slides

Webcast

Conclusions and perspectives 

Presenter: Lars Bullinger

Session: How diagnostic tools impact therapy of haematological malignancies

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.